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1  | INTRODUC TION
Aging is a multifactorial condition associated with complex changes 
occurring virtually in  every cell of our body (Kirkwood, 2008; 
López‐Otín, Blasco, Partridge, Serrano, & Kroemer, 2013). Changes 
underlying aging are characterized by the chronic accumulation of 
molecular and cellular damage throughout the lifespan, and by the 
following cellular response to stress by activating mechanisms that 
support cellular functions and hence maintain cellular homeostasis. 
Indeed, organisms have developed different mechanisms to coun‐
teract the potentially deleterious effects of aging to maintain their 
homeostasis and increase their lifespan and functionality, but in the 
end, aging is a normal stage of life, and all organisms must obey to it.
As the brain ages, different chemical, structural, and func‐
tional changes occur, that eventually translate into changes in cog‐
nitive function (Mattson & Magnus, 2006). Among the alterations 
that occur in the brain with aging, alteration of brain proteome 
homeostasis is one of the best described. For example, differences 
between young and old brain proteomes can subsist at different lev‐
els, such as differences in the magnitude of protein expression, post‐
translational modifications, and protein folding stability (Roberts, 
Liu, Karnuta, & Fitzgerald, 2016; Stauch, Purnell, Villeneuve, & 
Fox, 2015; Vanguilder & Freeman, 2011). Additionally, recent evi‐
dence shows how alteration of the brain proteome that occurs with 
aging also include changes in the subcellular localization of proteins 
between the young and old brain. Age‐dependent differences in 
subcellular localization of proteins, specifically changes in cytosolic‐
nuclear localization, have been linked to decreased neuronal func‐
tionality and, consequently, to an increased propensity of developing 
neurological disorders. Therefore, in this mini‐review, I will focus on 
the changes in cytosolic‐nuclear localization of proteins, and in the 
alteration of the nucleocytoplasmic transport, which occur during 
brain aging, and its potential effect on neurodegenerative disorders.
2  | AGE‐DEPENDENT ALTER ATION 
IN NUCLE AR IMPORT–E XPORT 
FUNC TIONALIT Y
The trafficking of proteins and large molecules between the cy‐
toplasm and the nucleus is mainly governed by the nuclear pore 
complexes (NPCs), large protein complexes that span the nuclear 
 
Received:	13	December	2018  |  Revised:	10	April	2019  |  Accepted:	6	May	2019
DOI: 10.1002/jnr.24446  
R E V I E W
Nucleus–cytoplasm cross‐talk in the aging brain
Stefano Benvegnù
Department of Molecular Neuropathology, 
Centro de Biología Molecular “Severo 
Ochoa”, CSIC‐UAM, Madrid, Spain
Correspondence
Stefano Benvegnù, Department of 
Molecular Neuropathology, Centro de 
Biología Molecular “Severo Ochoa”, CSIC‐




Aging is a primary risk factor for fatal neurodegenerative disorders, yet the mecha‐
nisms underlying physiological healthy aging and pathological aging, and how these 
mechanisms can divert one scenario to the other, are not completely understood. In 
recent years, reports indicate that alterations in nucleocytoplasmic transport may 
be a hallmark of both healthy and pathological aging. In this review, I summarize re‐
cent evidence supporting this information, specifically focusing on the association 
between the nucleocytoplasmic transport and aging of the brain, indicating both 
common and case‐specific mechanisms and their interplay, and pointing out altera‐
tions of these mechanisms as regulatory “switches” for the fate of the aging brain. 
Importantly, some of these alterations are intervenable druggable targets, paving the 
way to a future pharmacotherapeutic intervention.
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envelope (Wente & Rout, 2010). The functions of the NPCs and 
of the nuclear envelope go far beyond the simple regulation of 
trafficking macromolecules, and have been implicated in other 
unrelated cellular processes, including cell cycle progression, regu‐
lation of gene expression, and anchoring sites for chromosomes 
and cytoskeletal components to the nuclear periphery (reviewed 
by (D'Angelo & Hetzer, 2006)). NPCs in postmitotic neurons do 
not turn over and are extraordinarily long‐lived (D'Angelo, Raices, 
Panowski, & Hetzer, 2009; Savas, Toyama, Xu, Yates, & Hetzer, 
2012). Without mitotic turnover, NPC components become oxi‐
dized after exposure to aging‐derived toxic metabolites; this results 
in the progressive deterioration of NPC function, and the conse‐
quent leakage of cytosolic proteins into the nuclear compartment 
of neurons (D'Angelo et al., 2009). A study to analyze differences 
in proteome between young and old brains in rats reports an al‐
tered cytoplasmic‐nuclear localization of proteins (Ori et al., 2015). 
In this study, the authors fractionated the homogenates in different 
subcellular fractions (among which nuclei, postnuclear membranes, 
and cytoplasmic fractions) prior to spectrometric analysis of young 
and old rat brains lysates. The authors identified that seven pro‐
teins in the brain had opposite subcellular distribution (i.e., an 
increased abundance in one compartment counterbalanced by a 
decrease in another) between young and old brains. As this change 
could not be explained by changes in translation output, the au‐
thors therefore interpreted such data as indicative of a real change 
in subcellular localization that occurs with aging of the brain. The 
differentially redistributed proteins include protein and RNA modi‐
fying enzymes, proteins involved in translation, and nuclear trans‐
port factors. For example, the authors identified that Exportin‐5, a 
NPCs‐interacting protein involved in the export of miRNAs (Lund, 
Güttinger, Calado, Dahlberg, & Kutay, 2004) and tRNAs (Calado, 
Treichel, Müller, Otto, & Kutay, 2002), shows an increased abun‐
dance in the cytoplasm of cells from old brains, implying a potential 
alteration of nuclear transport activity. These data, in accordance 
with the previously described age‐dependent deterioration of the 
NPC (D'Angelo et al., 2009), indicate a modification of protein and 
RNA transport machineries associated with brain aging.
3  | NPC S,  NUCLE AR L AMINA , AND 
OXIDATIVE STRESS
The correct functioning of NPC is also strictly dependent on the 
integrity of the nuclear lamina, a fibrillar protein structure lining 
the inner surface of the nuclear envelope important to maintain 
nuclear stability, organize chromatin, and bind NPCs (Cobb et al., 
2016; D'Angelo et al., 2009; Sakuma & D'Angelo, 2017). Alteration 
of the nuclear lamina is strongly associated with premature aging 
and diseases.
3.1 | Hutchinson‐Gilford progeria syndrome and 
nucleocytoplasmic transport alteration
Mutations of the gene LMNA coding for Lamin A are associated 
with premature aging syndromes, such as Hutchinson‐Gilford pro‐
geria syndrome (HGPS) (Liu, Barkho, et al., 2011a; Liu, Suzuki, et 
al., 2011b). HGPS is an extremely rare genetic disorder charac‐
terized by the rapid appearance of aging beginning in childhood. 
Affected children develop a characteristic facial appearance (small 
chin, prominent eyes, protruding ears). Additional typical features 
include cardiovascular disease and stroke, atherosclerosis, hip dis‐
locations, and other abnormalities. Individuals with HGPS die of 
heart disease at an average age of 13 years, with a range of about 
8 to 21 years (Piekarowicz, Machowska, Dzianisava, & Rzepecki, 
2019; Ullrich & Gordon, 2015). Mutant lamins trigger nuclear lam‐
ina abnormalities, make the nuclear envelope unstable, and pro‐
gressively damages the nucleus, in turn making cells more likely 
to die prematurely (Prokocimer, Barkan, & Gruenbaum, 2013). 
Accumulation of a truncated form of Lamin A results also in dys‐
functional nuclear import (Kelley et al., 2011) and an increase in 
oxidative stress (Richards, Muter, Ritchie, Lattanzi, & Hutchison, 
2011). An increase in oxidative stress is a well‐described age‐re‐
lated factor, and is one of the most important key events in in‐
ducing both (physiological) organism aging and (pathological) 
neurodegeneration (Bokov, Chaudhuri, & Richardson, 2004; Cui, 
Kong, & Zhang, 2012; Mattson & Magnus, 2006; Stranahan & 
Mattson, 2012). In young cells, a physiological composition of the 
nuclear envelope is fundamental to counteract oxidative stress. 
For example, conserved cysteine residues in the Lamin A tail do‐
main are targets for irreversible oxidative damage during replica‐
tive senescence. These cysteine residues work as a “buffer” system 
of the cell to counteract oxidative stress. Indeed, in the absence of 
Lamin A or after the loss of the conserved cysteine residues, reac‐
tive oxygen species (ROS) basal levels are elevated and cells enter 
a premature state of senescence following only mild levels of ROS 
stimulation (Pekovic et al., 2011; Sieprath et al., 2015).
Another example of the interplay between nuclear lamina and 
oxidative stress is the case of Oct‐1. Oct‐1 is a transcription fac‐
tor essential for the regulation of stress response genes to preserve 
cells from oxidative stress‐mediated damage. Oct‐1 is also known 
to interact with Lamins (Malhas, Lee, & Vaux, 2009). Different 
Oct‐1‐dependent genes, including a subset of genes involved in 
Significance
Alteration of nucleocytoplasmic transport is increasingly 
reported as a major mechanism of loss of homeostasis and 
neurotoxicity during aging and neurodegeneration. Age‐de‐
pendent increase in oxidative stress, perturbation of proteo‐
stasis, accumulation of protein aggregates, together with the 
uniqueness of neurons as nondividing, long‐living cells in the 
body, are among the main causes for the improper nucleocy‐
toplasmic transport observed during aging. This review tries 
to combine the main evidences for all the above‐mentioned 
points, in order to clarify potential interrelated mechanisms 
and to provide a wider scenario of the nucleocytoplasmic 
transport defects in an aging neuron.
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the response to oxidative stress, are dysregulated in cells lacking 
LMNB1. Additionally, Oct‐1 binds to the putative octamer‐binding 
sequences of the dysregulated genes, and this activity is increased 
in cells lacking functional Lamin B1. This indicates that Oct‐1 exerts 
a negative, repressive effect on transcription of oxidative stress re‐
sponse genes. In the absence of Lamin B1 (Malhas et al., 2009) or 
with senescence‐induced decreased levels of Lamin B1 (Shimi et al., 
2011), cells have elevated levels of ROS and are more susceptible to 
oxidative stress. Therefore, Lamin B1 sequesters Oct‐1 at the nu‐
clear periphery and prevents it from fully entering the nucleus and 
exercising its negative transcriptional function. An abnormal efflux 
of Oct‐1 from the nucleus was also observed in cells lacking Lamin 
A/C (De Vos et al., 2011). In summa, these effects indicate that the 
nuclear envelope, by physically sequestering transcription factors 
out of DNA‐binding regions, can regulate gene expression and con‐
tribute to the cellular response to oxidative stress and aging, and 
that changes in lamina composition can therefore lead to alterations 
in nucleocytoplasmic compartmentalization and alter the proper 
cellular response to stress.
Changes in nucleocytoplasmic compartmentalization may not 
be solely due to reduced NPC functionality, but also to other fac‐
tors such as changes in the Ran gradient. The small GTPase Ras‐re‐
lated nuclear protein (Ran) regulates the ability of both importins 
and exportins to transport their cargo across the nuclear mem‐
brane. This transport regulation by the Ran GTPase requires its 
nuclear localization and GTP loading by the chromatin‐associated 
exchange factor RCC1. In fact, RCC1 is preferentially located in‐
side the nucleus, while Ran GTPase‐activating proteins (GAPs) that 
catalyze the hydrolysis of GTP to GDP are located exclusively in 
the cytoplasm (Stewart, 2007). This creates a Ran protein gradient 
used by importins and exportins for a physiologically directional 
nucleocytoplasmic transport. However, cellular stress such as ox‐
idative stress can disrupt Ran gradient (Stochaj, Rassadi, & Chiu, 
2000; Yasuda, Miyamoto, Saiwaki, & Yoneda, 2006). For example, 
cells from patients with HGPS have elevated ROS and a disrupted 
Ran protein gradient (Bischoff & Ponstingl, 1991; Datta, Snow, 
& Paschal, 2014; Kelley et al., 2011; Viteri, Chung, & Stadtman, 
2010). Similarly to what occurs with Lamin A (Pekovic et al., 2011; 
Sieprath et al., 2015), cysteine residues on RCC1 are oxidized in 
cells exposed to oxidant agents (Chatterjee & Paschal, 2015). The 
cysteine oxidation reduces RCC1 binding to RanGDP, inhibited 
nuclear import and disrupt Ran protein gradient. Interestingly, the 
pharmacological inhibition or depletion of NAT10, a nucleolar acet‐
yltransferase that regulates acetylation of microtubules during cell 
division (Shen et al., 2009), rescues many phenotypes of cells from 
patients with HGPS including assembly of the nuclear pore com‐
plex, chromatin organization, nuclear Ran localization and import 
of nuclear proteins (Larrieu, Britton, Demir, Rodriguez, & Jackson, 
2014; Larrieu et al., 2018). These results underscore a potential 
pharmacological therapeutic strategy for HGPS, and consequently 
also for other age‐associated pathologies with impaired nucleocy‐
toplasmic transport.
3.2 | Adult‐onset autosomal dominant 
leukodystrophy: The role of Lamin B in 
neurodegeneration
The nuclear lamina‐dependent effects on transcription are pro‐
posed to be at the bases not only of aging‐related processes, but 
also of neurodegenerative states, such as in adult‐onset autosomal 
dominant leukodystrophy (ADLD). ADLD is a very rare demyelinat‐
ing neuropathy of the central nervous system that presents itself in 
the fourth or fifth decade of life (Lin, Ptácek, & Fu, 2011; Padiath 
et al., 2006). This disorder is often associated with early autonomic 
symptoms preceding ataxia and pyramidal abnormalities. In ADLD 
patients, defects in brain white matter are observed, particularly in 
the cerebellum, corticospinal tracts, and corpus callosum, leading to 
brain and spinal cord atrophy (Sundblom, Melberg, Kalimo, Smits, 
& Raininko, 2009). ADLD has been shown to be caused by duplica‐
tions involving the gene LMNB1 on the chromosome 5q32 (Padiath 
et al., 2006). The duplication of LMNB1 gene leads to an increased 
expression of Lamin B1 protein and mRNA in brain tissue. Increased 
expression of Lamin B1 results in perturbations of inner nuclear 
membrane proteins, chromatin organization, and nuclear pore trans‐
port (Lin & Fu, 2009). One proposed mechanistic model for the dis‐
ease is that the increased expression of Lamin B1 suppresses the 
transcription and the consequent lack of myelin basic protein and 
proteolipid protein in oligodendrocytes, therefore, leading to central 
myelin failure (Lin et al., 2011).
In summary, in the context of neuronal aging, the increase in 
oxidative stress and the consequent build up of damage to nuclear 
pores and nuclear lamina components that occurs during a lifespan 
affects the proper nucleocytoplasmic transport by affecting the 
long‐lived nuclear pore proteins as described (D'Angelo et al., 2009). 
These effects alter the proper cellular transcriptional response that 
counteracts the increased oxidative stress conditions. As a result, 
the sum of all these conditions can culminate in a substantial, func‐
tional abrogation of NPC function in safeguarding the intranuclear 
material, paving the way to the pathogenesis of aging‐related neuro‐
nal dysfunction and, in turn, neurodegeneration.
4  | PROTEIN AGGREGATES AFFEC T 
NUCLEOCY TOPL A SMIC TR ANSPORT 
DURING BR AIN AGING AND DISE A SE
During aging, proteins are damaged or chemically modified by reac‐
tive substances such as oxidants and glycans. Such modified proteins 
are not usually functional, improperly folded, and potentially toxic to 
the cell (Höhn, Jung, & Grune, 2014), and are consequently removed 
by cellular proteolytic systems. However, during aging, the activ‐
ity of these systems decrease (Bingol & Sheng, 2011; Keller, Gee, & 
Ding, 2002; Keller, Hanni, & Markesbery, 2000). Together with this, 
the accumulation of reactive species leads to the accumulation of 
damaged proteins and the build up of protein aggregates (Nowotny, 
Jung, Grune, & Höhn, 2014). The accumulation of these aggregates 
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interferes with the normal cellular homeostasis and affect the whole 
neuronal metabolism, and is one of the key aspects responsible not 
only for the increased neuronal vulnerability during aging, but it can 
also lead to the onset of age‐related disorders (David, 2012; Mattson 
& Magnus, 2006). As neurons are postmitotic cells, they cannot dis‐
sipate protein aggregates simply by cell division, and the age‐related 
decline of the degradation systems further enhances the vulner‐
ability of neurons. Additionally, the peculiar polarized structures of 
neurons (dendrites and axon) can additionally contribute to neuronal 
vulnerability to altered proteostasis associated with protein aggre‐
gates. For example, autophagosomes (a key structure of autophagy‐
dependent intracellular degradation of proteins) are formed at the 
distal ends of neurons (Maday, Wallace, & Holzbaur, 2012; Yue, 
Wang, & Komatsu, 2008) and then undergo retrograde transport 
to the soma along the axons (Wong & Holzbaur, 2014). As axonal 
transport activity is essential for supporting physiological neuronal 
function, perturbation of proteostasis, and the consequent accumu‐
lation of protein aggregates can cause a blockage in the traffic of 
proteins and cargoes in the axon, leading to neuroaxonal dystrophy 
and, eventually, to neurodegeneration.
Moreover, the physiological aggregation of non‐disease‐related 
proteins in the context of aging can lead to the aggregation of dis‐
ease‐related protein, and therefore switch a normal, physiological 
aging into a pathological aging phenotype (David, 2012; Münch & 
Bertolotti, 2010). For example, age‐dependent physiological aggre‐
gates could titrate anti‐aggregation factors away from disease‐ag‐
gregating proteins (Salomons et al., 2009) or could directly induce 
the aggregation of disease‐related proteins by a cross‐seeding 
mechanism (Münch & Bertolotti, 2010; Olzscha et al., 2011).
4.1 | Huntington's disease
Protein aggregates are at the basis of all the major neurodegenera‐
tive disorders including Prion disorders, Alzheimer's disease (AD), 
Parkinson's disease (PD), Huntington's disease (HD), and amyo‐
trophic lateral sclerosis (ALS) (Ross & Poirier, 2004). Among the 
different types of neurodegeneration‐linked aggregates, one of the 
best characterized to pathologically contribute to the alteration 
of nuclear transport are the aggregates of the protein Huntingtin 
(HTT), the pathological hallmark of Huntington's disease (HD). HD is 
one of the most prevalent dominantly inherited neurodegenerative 
diseases. HD patients suffer from a clinical triad of movement dis‐
order, psychiatric symptoms, and cognitive impairment. The disease 
is caused by a CAG repeat expansion encoding an elongated poly‐
glutamine stretch near the N terminus of Huntingtin (Bates et al., 
2015). The disease mechanisms downstream of mutant HTT (mHTT) 
expression suggest that the expansion of polyglutamine trait elicits 
gain‐of‐function proteinopathy that may affect both nuclear and cy‐
toplasmic cellular function (Bates et al., 2015). mHTT misfolds and 
forms aggregates both in the nucleus and in the cytoplasm of af‐
fected neurons, and these aggregates are the histopathological hall‐
mark of the disease. Genetic manipulations that force the nuclear 
translocation of mHTT exacerbate the pathogenesis of the disease in 
mouse models (Gu et al., 2015). Interestingly, a recent study by Grima 
and colleagues (Grima et al., 2017) provides evidence of a compro‐
mised nuclear pore function in HD models. In this study, the authors 
test the hypothesis that mHTT may selectively impair specific NPC 
proteins and soluble transporters. Indeed, they found several nucle‐
oporins (NUPs) and NUP‐associated proteins such as RanGAP1 (as 
in Gasset‐Rosa study, discussed below), Nup88, and Nup62 as mis‐
localized and partially sequestered by mHTT in the striatum and in 
the cortex of THE R6/2 mouse model of HD and in the postmortem 
human striatum tissue from HD patients. RanGAP1 is a GTPase‐acti‐
vating protein located on the cytoplasmic filaments of the NPC that 
is required for nuclear export and import. High levels of Ran‐GTP 
inside the nucleus compared to the cytoplasm is fundamental for a 
physiological active transport through the NPC (Floch, Palancade, 
& Doye, 2014). The correct maintenance of the nuclear‐cytoplasmic 
Ran gradient mediated by RanGAP1 is critical for cell survival; in‐
deed, its loss has been demonstrated to induce cell death (Hetzer, 
Gruss, & Mattaj, 2002). By reducing the levels of mHTT, the authors 
could normalize RanGAP1 levels. Indeed, intrastriatal injection in 
R6/2 mice models of HD of microRNA to reduce the levels of PIAS1, 
an E3‐SUMO ligase that modulates SUMO‐1 and SUMO‐2/3 modi‐
fication of HTT (O'Rourke et al., 2013; Ochaba et al., 2016), reduces 
formation of high molecular weight species of mHTT aggregates and 
restores the levels of nuclear RanGAP1. On the contrary, transient 
expression of mHTT in primary cortical neurons phenocopies the 
nuclear pore leakiness, the deficiency in active nuclear transport, 
and the mislocalization of RanGAP1 as identified in HD. Accordingly, 
increasing RanGAP1 levels in fly models expressing mHTT reduces 
neurodegeneration and increases the lifespan. Pharmacological in‐
tervention with CRM1 inhibitor KPT‐350 or KPT‐276 reduced cell 
death and rescued nucleocytoplasmic trafficking defects in primary 
cortical neurons, pointing to the inhibition of nuclear export as a 
neuroprotective mechanism through the compensation of impaired 
nuclear import in HD.
In support of the findings by Grima and colleagues, a study by 
Gasset‐Rosa and colleagues (Gasset‐Rosa et al., 2017) confirmed and 
expanded the knowledge on an altered nuclear transport in HD. By 
analyzing the striatum and the cortex (two HD vulnerable brain re‐
gions) of different mouse models expressing mHTT, and using HD 
patients‐induced pluripotent stem cells (iPSC)‐derived neurons and 
HD postmortem brains, the authors identified several defects in the 
nuclear membrane and NPC components, such as altered nuclear 
membrane shape, mislocalization, and aggregation of the protein 
RanGAP1, NUP62 and Gle1, an export factor for mRNA. The aggre‐
gates of mHTT in the nucleus partially sequester these components, 
suggesting a potential functional depletion mechanism. Indeed, 
mRNA was shown to progressively and aberrantly accumulate in the 
nucleus of HD neurons. Additionally, in HD mouse models the nu‐
clear envelope and lamina are improperly folded, causing alterations 
both in passive and in active permeability through the NPC, and an 
increase in DNA double‐strand breaks. Aberrant nuclear architec‐
ture is a typical cellular hallmark of aging (López‐Otín et al., 2013; 
Scaffidi & Misteli, 2006). In order to investigate whether mHTT 
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induces nuclear envelope alterations in mice models of HD, the au‐
thors analyzed the nuclear shape in cortex and striatum by defining 
two different types of nuclear morphology: the “normal” morphol‐
ogy, typical of young neurons, where nuclear lamina is predominantly 
round and regular in shape; and the “altered” morphology, with alter‐
ations (from moderate to severe) and with an irregular shape of nu‐
clear lamina showing several invaginations or protrusions. In all the 
HD models under investigation, the authors identified mHTT‐dose‐
dependent and age‐dependent nuclear envelope alterations, with 
up to 95%–100% of neurons under investigation presenting nuclear 
architecture abnormalities at late stages of the disease. The authors 
confirmed the relevance of this finding by analyzing the nuclear mor‐
phology within the motor cortex of two HD patients and two control 
individuals, identifying a significant increased number of misshapen 
nuclei in HD patients compared to control individuals.
The authors describe the entire scenario as an exacerbated con‐
dition of physiological neuronal aging, in which nuclear envelope 
and lamina show a commencement of improper folding, the pore 
permeability is slightly increased, mRNAs start to accumulate in the 
nucleus and RanGAP1 begins to aggregate on the nuclear surface.
In summary, the underlying concept is that, in HD, mHTT is ac‐
celerating and exacerbating neuronal dysfunction (i.e., NPC loss‐of‐
functionality, defects in nuclear shape, defects in nucleocytoplasmic 
compartmentalization) observed during healthy, physiological brain 
aging.
4.2 | AD and tauopathies
Another disease‐related, aggregation‐prone protein known to dis‐
rupt nucleocytoplasmic transport is protein tau. Tau is the main 
constituent of neurofibrillary tangles observed in AD. While tau 
aggregation and phosphorylation are established hallmarks of AD, 
the mechanisms underlying tau‐associated neuronal dysfunction 
and damage are still uncertain. Very recently, phosphorylated tau 
was shown to alter nucleocytoplasmic transport by directly interact‐
ing with Nup98, a nucleoporin of the NPC, in hippocampal neurons 
from AD patients (Eftekharzadeh et al., 2018). When interacting 
with Nup98, tau forces the mislocalization of Nup98 outside the 
NPC, rendering the nuclear pore leaky. Once in the cytosol, Nup98 
interacts directly with phospho‐tau and facilitates its aggregation. 
By knocking down the expression of tau, it was possible to restore 
Nup98 defects and nucleocytoplasmic defects in the hippocampus 
of rTg4510 mice, a rodent model of AD. It seems therefore that tau‐
dependent neurotoxicity (in AD and in other tauopathies) could be at 
least mediated by phospho‐tau‐induced NPC dysfunction.
Autosomal‐dominant mutations in the MAPT gene coding for Tau 
protein cause a form of inherited frontotemporal dementia (FTD). 
In a very recent report by Paonessa and colleagues (Paonessa et al., 
2019), the authors identify that mutant hyperphosphorylated tau 
mislocalizes from the axon to the cell body and dendrites in corti‐
cal neurons. The new mislocalization of tau in the cell body leads 
to abnormal microtubule movements in FTD‐MAPT neurons that 
deform the nuclear membrane. This in turn results in a defective 
nucleocytoplasmic transport. The authors suggest that the presence 
of tau in the cell body promotes an aberrant microtubule stability, 
and that this effect leads to increased pushing forces on the nuclear 
membrane and to the consequent formation of invaginations in the 
nuclear membrane. Interestingly, acute treatment of FTD‐MAPT 
cortical neurons with the microtubule depolymerization molecule 
nocodazole reduced the proportion of neurons with nuclear invag‐
inations, restored the round nuclear morphology and restored the 
nucleocytoplasmic transport to the level of healthy control neurons.
As the rescue of nuclear shape and of nucleocytoplasmic trans‐
port via microtubule reorganization (by NAT10 tubulin acetyltrans‐
ferase inhibition) was achieved in another age‐related syndrome, the 
HGPS (Larrieu et al., 2014), it would be of interest to see whether, 
by exchanging the treatments, the two phenotypes could still be re‐
verted. This would indicate microtubule dynamics as a potential 
therapeutic target not only for the two cited pathologies, but more 
generally for any disease with altered nuclear shape and nucleocy‐
toplasmic transport.
In summary, both studies underlie how alteration in the metabo‐
lism of microtubule‐associated tau protein, a typical hallmark of AD 
and Tauopathies, is responsible for alteration in nucleocytoplasmic 
transport. This finding points at microtubule dynamics and stability 
as a potential pathophysiological mechanism that could be targeted 
for potential therapeutic interventions in AD, FTD, and other neuro‐
degenerative diseases.
4.3 | FTD and ALS
Other neuropathological disorders markedly linked to nuclear trans‐
port alterations are FTD and ALS (Gijselinck, Cruts, & Broeckhoven, 
2018). The repeat expansion of the hexanucleotide GGGGCC (G4C2) 
in a noncoding region of the C9orf72 gene is the most common cause 
of sporadic and familial form of these disorders, but the molecular 
mechanisms of neurodegeneration are quite unknown. While a 
low number of G4C2 repeats are associated with healthy individu‐
als, an increased repeat number is observed in diseased patients. 
Different theories attempt to explain the pathogenic mechanisms 
of the disease: (a) Loss‐of‐function of the protein (C9orf72 haploin‐
sufficiency)—the expanded repeats interfere with the physiological 
transcription or translation of the protein, leading to a decreased ex‐
pression level of the coded protein; (b) RNA‐mediated gain‐of‐func‐
tion—expanded repeats form nuclear RNA foci that sequester and 
deplete essential RNA‐binding proteins, leading to neurotoxicity; 
(c) Protein‐mediated gain‐of‐function—the expanded repeats are 
translated into a potential toxic dipeptide repeat protein via an un‐
conventional translational mechanism (Repeat‐Associated Non‐ATG 
initiated (RAN) translation (Zu et al., 2011)) which evades the re‐
quirement for a canonical ATG start codon (see for review (Gendron 
& Petrucelli, 2018)).
In an attempt to investigate and clarify these mechanisms, 
three different studies discovered a clear association of the dis‐
ease causing mutation with a compromised nucleocytoplasmic 
transport. Rothstein's group (Zhang et al., 2015) showed how 
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C9orf72 repeat expansion affects the function of RanGAP1, sim‐
ilarly to the studies showing that RanGAP1 was altered by mHTT 
aggregates (Gasset‐Rosa et al., 2017; Grima et al., 2017). While the 
authors previously identified that RanGAP1 interacts with G4C2 
RNA, they also showed that RanGAP1 is mislocalized in flies, neu‐
rons from C9orf72 ALS patient‐derived induced pluripotent stem 
cells (iPSC‐derived neurons), and in C9orf72 ALS patient motor 
cortex and cerebellum tissue. Interestingly, overexpression of 
RanGAP1 in flies suppressed neurodegeneration, as well as phar‐
macological enhancing of nuclear import or blockade of nuclear 
export activity. Similar results were later identified in mouse mod‐
els that express the dipeptide repeats in their brain (Zhang et al., 
2016).
In parallel, Taylor's group (Freibaum et al., 2015) generated trans‐
genic fruit fly lines that expressed 8, 28, or 58 G4C2‐repeat‐contain‐
ing transcripts in their neurons. They identified a dose‐dependent 
harmful effect on neurodegeneration. After performing a genetic 
screen, in which the authors systematically mutated other genes of 
the fruit fly to identify those genes that ameliorated or worsened 
the neuronal damage, they identified 18 genetic modifiers encod‐
ing components of the nuclear pore complex. Specifically, the loss 
of two genes, NUP50 and Ref1 (Drosophila orthologs of human 
NUP50 and ALYREF) strongly enhanced or suppressed, respectively, 
neurodegeneration in the mutant flies. According to this result, the 
authors identified morphological abnormalities of the nuclear enve‐
lope and defects in RNA export in disease‐mimicking neurons.
Another	team	of	researchers	 led	by	Aaron	Gitler	 (Jovičić	et	al.,	
2015) focused more specifically on the toxicity mediated by the 
dipeptide repeats. The authors expressed in yeast each of the five 
dipeptide repeats produced by the unconventional RAN translation 
of the expanded G4C2. They identified that arginine‐containing di‐
pepdite repeats are the most toxic specie. By performing a genetic 
screen aiming to identify modifiers of the dipeptide repeats‐medi‐
ated toxicity (similar to the approach used by Taylor's group), the 
authors identified 11 genes that regulate nucleocytoplasmic trans‐
port (including karyopherins and effectors of Ran‐mediated nucle‐
ocytoplasmic transport). According to these results, the authors 
identified nucleocytoplasmic transport disturbance in C9orf72‐ALS 
patient‐derived neurons. A following study substantiated the results 
of the yeast genes also in drosophila (Boeynaems, Bogaert, Michiels, 
et al., 2016).
In summary, these three studies all converged on the same genes 
and pathways and identified that an impairment of nucleocytoplas‐
mic transport is a key factor for toxicity in models mimicking ALS‐
FTD and suggest therefore that this impairment can be a bona fide 
contributor to the initiation or to the progression of ALS‐FTD disor‐
ders in humans.
Another common histopathological hallmark in the brains of 
ALS/FTD patients is the cytoplasmic mislocalization of the (pre‐
dominantly nuclear) RNA‐binding TDP‐43 (transactive response 
DNA‐binding protein, 43 kDa) and the accumulation, in detergent‐
insoluble protein aggregates, of its aberrantly phosphorylated and 
ubiquitinated C‐terminal fragment (CTF) in neurons and glial cells 
(Igaz et al., 2008; Neumann et al., 2006). TDP‐43 is a 414 amino acid 
protein that is encoded by the TARDBP gene. It contains two RNA‐
recognition motifs and a glycine‐rich C‐terminal region that allow it 
to bind DNA, RNA, and proteins (Buratti et al., 2001, 2005; Wang, 
Wang, Bose, & Shen, 2004). Remarkably, the C‐terminal domain 
of TDP‐43 harbors the majority of the disease‐causing mutations 
responsible for ALS/FTD, which promote the cytoplasmic mislo‐
calization and neurotoxicity of TDP‐43 (Gitcho et al., 2008; Guo 
et al., 2011; Nonaka, Kametani, Arai, Akiyama, & Hasegawa, 2009). 
Although its physiological functions are still to be fully understood, 
TDP‐43 was shown to regulate gene transcription and mRNA metab‐
olism (from splicing, stability, transport, and translation, to the for‐
mation of cytoplasmic and nuclear stress granules) (Li, King, Shorter, 
& Gitler, 2013; Ratti & Buratti, 2016). Even if an aberrant sequestra‐
tion and aggregation of RNA‐binding proteins could lead to altered 
RNA and protein homeostasis, the precise molecular mechanism by 
which TDP‐43 cytoplasmic aggregation causes neurodegeneration 
remains to be elucidated.
In order to address this issue, Ching‐Chieh Chou and colleagues 
(Chou et al., 2018) investigated the composition of detergent‐insol‐
uble TDP‐43 and TDP‐43‐CTF aggregates by proximity‐dependent 
biotin identification (BioID). The authors identified that the cyto‐
plasmic aggregates are particularly enriched from components of 
nucleocytoplasmic transport pathways. Among the 254 TDP‐43‐
associated and the 389 TDP‐43‐CTF‐associated proteins identi‐
fied, a gene ontology cluster analysis revealed an enrichment in the 
functional categories of mRNA processing and splicing, intracellular 
protein transport and translation initiation. Interestingly, the au‐
thors identified nucleocytoplasmic transport components as one 
of the major groups of proteins interacting with TDP‐CTF aggre‐
gates. By co‐expression studies, the authors showed how expres‐
sion of TDP‐43‐CTF or of TDP‐43 expressing ALS‐linked missense 
mutations caused the mislocalization and cytoplasmic aggregation, 
to varying degrees, of transcription factors and nucleoporins iden‐
tified in the interactome screening, and that “prion‐like” domains 
expressed by nucleoporins and transcription factors were responsi‐
ble for the cytoplasmic aggregation with TDP‐43‐CTF. Aggregated 
and ALS‐linked mutant TDP‐43 were also shown to disrupt NPC 
and nuclear lamina morphology and nucleocytoplasmic transport, 
as revealed by a reduced nuclear import of the fluorescent reporter 
tdTomato protein flanked by NES and NLS sequences and by an in‐
creased nuclear retention of poly(A) RNAs in primary cortical neu‐
rons. The authors confirmed their findings both in human fibroblasts 
and in induced pluripotent stem cell‐derived neurons. Additionally, 
in vivo studies in Drosophila disease models for ALS showed how 
loss‐of‐function mutations in several nucleoporins suppressed ret‐
inal degeneration and larval motor dysfunction, two main pheno‐
types induced by the expression of mutant TDP‐43 in Drosophila 
motor neurons. These results indicate that at least some aspects of 
TDP‐43 toxicity depend on its deleterious effects on nucleocyto‐
plasmic transport machinery also in vivo. Nuclear pore pathology 
was confirmed also in human ALS brain specimens, as evidenced by 
nucleoporins‐positive cytoplasmic inclusions and colocalization with 
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TDP‐43‐positive inclusions in motor cortex, hippocampus, and fron‐
tal cortex. Finally, the authors show how the suppression of TDP‐43 
toxicity, either by pharmacological intervention (via inhibition of 
CRM1‐dependent nuclear export) or by molecular intervention (via 
overexpression poly(A)‐binding protein nuclear 1, PABPN1, a potent 
suppressor of TDP‐43 toxicity and aggregation), rescues the defec‐
tive nucleocytoplasmic transport function.
4.4 | Both disease‐associated and  
non‐disease‐associated aggregates alter 
nucleocytoplasmic transport
In line with the finding that protein aggregates can alter nucleocy‐
toplasmic transport and contribute to brain dysfunction, Woerner 
and colleagues (Woerner et al., 2016) reported that β‐sheet‐rich 
aggregates also trigger a similar neurotoxic effect. Using artificial 
aggregation‐prone proteins, as well as authentic disease proteins 
(fragment of mHTT and TDP‐43), the authors show that the ag‐
gregates caused the segregation of proteins containing disordered 
and low‐complexity sequences such as nuclear import and export 
factors (such as THOC2, discussed below). In turn, this aggregation 
in the cytosol interfered with nucleocytoplasmic transport. Indeed, 
nuclear transport of proteins was altered (as evidenced by the al‐
tered transport of GFP reporter proteins carrying nuclear export 
(NES) and nuclear localization (NLS) sequence). Additionally, defects 
on mRNAs transport, and consequently a substantial nuclear ac‐
cumulation and concomitant cytosolic reduction of mRNAs, were 
triggered by the presence of the cytosolic aggregates. How do pro‐
tein aggregates achieve these effects? The authors show how the 
expression of the protein aggregates in the cytoplasm altered the 
distribution of NPC proteins, and partially dislocated NPC proteins 
to the cytoplasmic aggregates. Interactome analysis of the protein 
aggregates identified how the aggregates sequester several proteins 
involved in nuclear transport, including importins and components 
of the THO (suppressor of the transcriptional defects of hpr1Δ by 
overexpression) complex involved in mRNA export (Olzscha et al., 
2011; Woerner et al., 2016). Therefore, as in the case highlighted by 
Grima and Gasset‐Rosa, protein aggregates are shown to alter nucle‐
ocytoplasmic transport of proteins and mRNA potentially by binding 
to proteins associated to the NPC, and by virtue of this, induce the 
destabilization of the proper nuclear import‐export of both proteins 
and mRNA. As protein aggregates are hallmarks not only of patho‐
logical, neurodegenerative brains (Ross & Poirier, 2004), but are 
also present and produced during normal, physiological brain aging 
(David, 2012; Grimm, Hoehn, Davies, & Grune, 2011; Kumar, Taha, 
Sharma, Kale, & Baquer, 2008), the general mechanism described by 
Woerner and colleagues can explain how an alteration of the proper 
nuclear‐cytoplasmic flow can be triggered both in diseased and in 
non‐diseased state. Moreover, while this mechanism can underlie 
some aspects of the neuronal dysfunction during healthy aging, it 
can also be at the base of the worsened, impaired neuronal function‐
ing during pathological aging when neurons are challenged by the 
additional accumulation of aggregation‐prone proteins.
5  | NUCLE AR VERSUS CY TOSOLIC 
FUNC TION: THE C A SE OF MGRN1 IN THE 
AGING BR AIN
In line with the importance of a correct nuclear import‐export 
for proper neuronal aging is our recent study on the protein 
Mahogunin (Benvegnù, Mateo, Palomer, Jurado‐Arjona, & Dotti, 
2017). MGRN1 gene codes for the protein Mahogunin, a cytosolic 
CH3hCH4 RING type E3 ubiquitin ligase (Phan, Lin, LeDuc, Chung, 
& Leibel, 2002). Mutations of this gene in mice are responsible 
for the mahoganoid phenotype, that is, a complex phenotype that 
includes a darkening effect on color coat (Phan et al., 2002), an 
abnormal patterning of the left‐right axis (Cota et al., 2006), mito‐
chondrial dysfunction (Sun, Johnson, & Gunn, 2007), and an obe‐
sity‐rectifying effect on agouti mutant mice (Miller et al., 1997; 
Overton & Leibel, 2011). Interestingly, mice lacking MGRN1 also 
show a progressive neurodegenerative phenotype, first apparent 
in the hippocampus CA3 region at 2 months of age and later extend‐
ing to multiple regions of the brain (He et al., 2003), indicating that 
physiological levels of MGRN1 are neuroprotective during adult‐
hood and aging. Moreover, MGRN1 was later described to protect 
against oxidative and endoplasmic reticulum stress (Chhangani 
& Mishra, 2013), against cytosolic prions (Chakrabarti & Hegde, 
2009) and polyglutamine neurotoxic aggregates (Chhangani et al., 
2014), confirming that MGRN1 levels are crucial to provide general 
neuronal protection. We later described how MGRN1 levels can 
also be crucial for controlling the secretion of β‐amyloid peptides, 
the main component of amyloid deposits identified in the brains 
of AD patients (Benvegnù, Wahle, & Dotti, 2017). Starting from 
these observations, we analyzed a potential role for MGRN1 dur‐
ing aging of the animal and identified that MGRN1 levels chroni‐
cally decrease with aging in the hippocampus of mice. Moreover, 
during aging MGRN1 relocates to neuronal nuclei. The cytosol‐to‐
nucleus shift of MGRN1 is due to a decline in proteasomal activity, 
a typical event occurring with brain aging (Ding et al., 2002; Keller 
et al., 2002; Rousseau & Bertolotti, 2018; Schmidt & Finley, 2014). 
The decline in proteasomal activity induces the accumulation of 
protein aggregates (Saez & Vilchez, 2014). Therefore, considering 
the altered nucleocytoplasmic transport triggered by the presence 
of protein aggregates (as described above) typical of the aging 
brain, we cannot exclude that nuclear accumulation of MGRN1 
can be additionally influenced by the presence of such aggregates. 
Once in the nucleus, MGRN1 associates with active chromatin and 
with the transcription factor ATF3 (Activating Transcription Factor 
3), a main core point of the cellular adaptive‐response network to 
stress that is expressed in response to different types of stress‐
ors and provides an adaptive transcriptional response by binding 
to the promoter of target genes and regulating their transcription 
(Hai, Wolford, & Chang, 2010). Nuclear MGRN1, by interacting 
with ATF3 and possibly preventing its degradation, potentiates 
the transcriptional cellular response to proteasomal stress, and 
strengthens neuronal functionality. Proteasomal dysfunction, 
and in general the perturbation of protein homeostasis and of 
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the clearance mechanisms for damaged and misfolded proteins 
(Vilchez, Saez, & Dillin, 2014) can therefore have different con‐
sequences: (a) on one side, it induces the accumulation of neuro‐
toxic aggregates in neurons that interfere with nucleocytoplasmic 
transport (as described) consequently leading to altered subcel‐
lular accumulation of proteins; this altered subcellular localization 
can, in turn, lead to neuronal loss of homeostasis; (b) on the other 
side, the novel, altered localization of such proteins (as is the case 
of nuclear MGRN1 after proteasomal impairment) can be an adap‐
tive, compensatory response of the cell to a proteotoxic challenge.
MGRN1 likely plays a dual role as a component of the neuron ho‐
meostasis control system: one in the cytosol, as in young animals, to 
directly challenge cytotoxic aggregates and toxic stress; and one in 
the nucleus, in old animals, where in virtue of its “novel” localization 
in active chromatin regions it can participate in the orchestration and 
potentiation of the cellular response to proteotoxicity at transcrip‐
tional level. By increasing the levels of MGRN1 in vitro and in vivo, 
we could ameliorate signs of neuronal stress and aging, including 
cognitive decline in aged mice. MGRN1 cytosol‐to‐nuclear traffick‐
ing appears therefore not to be a toxic phenomenon, but rather an 
active mechanism of the cell in order to build up a proper response 
against stressful, toxic stimuli. A similar mechanisms is described for 
Nrf2, a nuclear transcription factor controlling the coordinated ex‐
pression of a set of protective genes encoding antioxidant proteins 
and detoxifying enzymes (Ma, 2013). Nrf2 is excluded from the nu‐
cleus by the major exportin CRM1. However, oxidants can modify 
and inactivate CRM1 function. The inactivation of CRM1‐mediated 
nuclear export consequently facilitates nuclear entry and accumula‐
tion of Nrf2 and transcriptional activation of Nrf2‐controlled genes, 
resulting eventually in an increase in the cellular antioxidant capabil‐
ity (Wang et al., 2009).
These findings rely on different mechanisms from the ones oc‐
curring, for example, with mHTT (Gasset‐Rosa et al., 2017; Grima 
et al., 2017), where nuclear accumulation of cytosolic proteins and 
mRNAs seems to be an uncontrolled event due to aging and, in an 
exacerbated manner, to Huntington's disease state. Such nuclear 
accumulation of cytosolic proteins and of mRNAs seems indeed to 
be nonfunctional, differently from the nuclear accumulation of cyto‐
solic MGRN1 observed with aging, where the nuclear accumulation 
of a cytosolically localized protein seems to be, on the contrary, an 
adaptive and neuroprotective response. One possible scenario ex‐
plaining this distinction can be a differential mechanism for the nu‐
clear accumulation of proteins, being this mechanism uncontrolled 
in the case of protein aggregates and the consequent alteration in 
nucleocytoplasmic transport, while regulated in the case of MGRN1 
nuclear entry. On the other hand, an uncontrolled nucleocytoplas‐
mic transport can lead to the nuclear accumulation not only of 
potentially toxic and aggregated proteins, but also of functional pro‐
teins that can exert their functions, as is the case of MGRN1 with 
ATF3, in a novel environment. In this perspective, additional studies 
need to clarify the nature and the potential “nuclear functionality” 
of proteins, normally localized in the cytosol in basal conditions, 
that accumulate in the nucleus as a consequence of the alteration 
of the (active and passive) nuclear transport observed in aging and 
in diseases.
6  | GLUCOCORTICOID RECEPTORS 
NUCLE AR ENTRY IS ALTERED IN BR AIN 
AGING
Additional proteins that exhibit altered nucleocytoplasmic transport 
during brain aging are the glucocorticoid receptors (GRs). The glu‐
cocorticoid receptors are intracellular receptors expressed virtually 
in all cells in the body. GRs bind to glucocorticoids which are se‐
creted by ACTH‐stimulated adrenal glands when the brain perceives 
a stressor (known as the hypothalamic‐pituitary‐adrenal (HPA) axis 
stress response (Smith & Vale, 2006)). In the absence of the hor‐
mone, the GR basally resides in the cytosol of the cell thanks to the 
help of several chaperone proteins (Pratt, Morishima, Murphy, & 
Harrell, 2006). Once cortisol diffuses through the plasma membrane 
and binds to GR, this results in the release of the chaperone proteins, 
consequently allowing the entry of the GR inside the nucleus. In the 
nucleus, GRs bind to specific DNA responsive elements and either 
activate or repress gene transcription (Weikum, Knuesel, Ortlund, & 
Yamamoto, 2017). In the brain, GRs are expressed ubiquitously and 
can function as nuclear activators or repressors. A tonic production 
and a transient increase in glucocorticoids during periods of stress are 
essential for neuronal plasticity and normal brain function (Aguilera, 
2011). As GR main signaling pathway is via nuclear entry and DNA 
binding, it is not surprising therefore that the interference with these 
two phenomena can lead to neuronal dysfunction. The activity of 
HPA axis during aging increases, as a consequence of an inefficient 
glucocorticoid negative feedback inhibition (Mizoguchi et al., 2009). 
One major consequence of this decrease in glucocorticoid nega‐
tive feedback inhibition is an altered GR signaling in neurons (Lee, 
Hwang, Yun, & Han, 2012), with consequences on neuronal survival 
and functionality, and in turn in memory (He et al., 2008; Hibberd, 
Yau, & Seckl, 2000). Mutations in GR that prevent DNA binding are 
associated with impaired spatial memory (Oitzl, Reichardt, Joëls, & 
Kloet, 2001). Importantly, a decreased DNA‐binding activity and 
a diminished nuclear entry of GR are described in neuronal aging 
(Murphy, Spencer, Sipe, & Herman, 2002). Moreover, GR levels were 
described to decrease only in the nucleus, but not in the cytosol, of 
hippocampal neurons of old rats with spatial memory impairment, 
with a consequently decreased GR DNA‐binding activity (Lee et al., 
2012). These observations suggest that the reduced nuclear levels of 
GR in old neurons can be the consequence of an altered nucleocyto‐
plasmic transport of GR. Upon binding to ligands, GR nuclear import 
through the nuclear pore is normally controlled by the interaction 
of nuclear pore complex proteins such as importins (Freedman & 
Yamamoto, 2004; Hakim, Barnes, Adcock, & Usmani, 2013; Tao, 
Lan, Lukacs, Haché, & Kaplan, 2006) and nucleoporins (Echeverría 
et al., 2009) with GR‐associated chaperone proteins (Davies, Ning, & 
Sánchez, 2002; Echeverría et al., 2009; Galigniana, Radanyi, Renoir, 
Housley, & Pratt, 2001; Wochnik et al., 2005). While an extensive 
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number of studies investigated the details of GR nuclear import in 
cells, an exhaustive description of the mechanisms leading to the 
decreased nuclear entry of GR as observed in neuronal aging is still 
missing. Nevertheless, this effect can be explained by a decrease in 
the expression levels, with aging, of chaperone proteins that are re‐
sponsible for GR nuclear translocation (Murphy et al., 2002). In fact, 
chaperones proteins HSP90 and the constitutively active HSC70 
are essential components of the chaperone complex (Rajapandi, 
Greene, & Eisenberg, 2000), which allow for high‐affinity glucocor‐
ticoid binding to GR (HSP70) and for the proper folding of the com‐
plex (HSC70). Aged rats showed marked decreases in hippocampal 
HSP90 and HSC70 levels in both nuclear and cytoplasmic extracts 
(Murphy et al., 2002). This decrease in chaperone proteins levels can 
therefore eventually participate in the altered glucocorticoid signal‐
ing described in hippocampal aging. In summary, the inappropriate 
HPA axis and GR signaling that occurs with brain aging can be, at 
least in part, due to age‐dependent inefficiency in the nuclear trans‐
location of GR. This GR‐dependent altered signaling with aging is 
not only relevant for age‐dependent neuronal alterations, but can 
improperly affect a health aging process and increase adverse ef‐
fects in stress‐related brain disorders (Aguilera, 2011).
7  | CONCLUSIONS
Brain aging is characterized by progressive changes in several neu‐
ronal molecular and cellular processes, among which a disturbance 
of nucleocytoplasmic transport and the presence of protein ag‐
gregates. These two features are observed during both healthy 
physiological brain aging and in neurodegenerative diseases, such 
as Huntington's disorder, AD, C9orf72‐linked, and TDP‐43‐linked 
FTD‐ALS. Mechanistically, protein aggregates trigger the dysfunc‐
tion of the nucleocytoplasmic transport, which in turn results in the 
additional accumulation of subcellularly mislocalized proteins, and in 
a consequent cellular dysfunction. As both non‐disease‐associated 
and disease‐associated proteins can alter the nuclear pore complex 
components and follow the same fate, these studies indicate there‐
fore that alterations of nucleocytoplasmic transport and of its com‐
ponents are a common, shared phenomenon between physiological 
and pathological brain aging (Figure 1).
Moreover, the parallels evidenced in these reports between 
neurons that are in a diseased, neurodegenerative scenario (i.e., HD, 
Mahoganoid mice, FTD‐ALS, …), and wild‐type aging neurons, they 
all suggest that: (a) the maintenance of a correct nuclear import–ex‐
port trafficking (and a potential therapeutic intervention for rescuing 
a dysfunctional nuclear transport) is pivotal for maintaining a physio‐
logical neuronal homeostasis and functionality; and (b) “pathological 
aging” can be a form of “physiological aging” accelerated and exacer‐
bated by some genetic factors and/or disease mechanisms that per‐
turb nucleocytoplasmic transport and maintain and extend neuronal 
dysfunction till the onset of a disease state.
Is there a common mechanism that links physiological aging to 
neurodegeneration? The question is still to be resolved; nevertheless, 
oxidative stress could be one of these mechanisms. In regards 
to physiological aging processes, an increase in oxidative stress bio‐
markers was shown to correlate with high levels of inflammatory 
cytokines, and both indicators were associated with low cognitive 
performance in institutionalized elderly persons (Baierle et al., 2015). 
Coherently, cognitive impairment was shown to be slower in old pa‐
tients with high glutathione peroxidase antioxidant activity (Revel et 
al., 2015). Reactive oxygen and nitrogen species (RONS) accumulate 
during physiological aging, inducing oxidative damage to macromol‐
ecules such as lipids, DNA, and proteins (Beckman & Ames, 1998; 
Liguori et al., 2018), and NPC is no exception (D'Angelo et al., 2009). 
Oxidative damage to proteins is also responsible for protein aggre‐
gation during physiological aging (Squier, 2001). Therefore, oxidative 
stress can impair NPC function both directly, via oxidant damage to 
NPC components, and indirectly, via protein aggregates‐mediated in‐
hibitory effect on NPC activity (Figure 1, central part). As in aging the 
oxidative stress is a chronic condition, there is an enhanced amyloid‐
like aggregation affecting both non‐disease‐associated and disease‐
associated proteins (Chen & Liu, 2017). Additionally, the presence 
of non‐disease‐associated protein aggregates, or the presence of 
pathogenic mutations, together with the persistent oxidative stress 
accompanied by aging, can accelerate a transition to a neuropatho‐
logical scenario, where protein aggregates (both disease‐associated 
and non‐disease‐associated) and RONS furthermore deteriorate and 
aggravate NPC functions (Figure 1, right part). Mitochondria are one 
of the main sources of ROS during aging (Cui et al., 2012; Stefanatos 
& Sanz, 2018). Therefore, any age‐related mechanism interfering with 
mitochondria metabolism can be potentially connected also to oxida‐
tive stress production. Can MGRN1 be a link between brain aging 
and ROS production? Mice lacking MGRN1 present mitochondrial 
dysfunction months before the onset of neuronal degeneration (Sun 
et al., 2007). Additionally, MGRN1 was shown to regulate mitochon‐
dria dynamics (i.e., fusion), and that loss of MGRN1 levels induces 
an increase in ROS levels in HeLa cells (Mukherjee & Chakrabarti, 
2016). We showed how loss of MGRN1 increases ROS levels also 
in primary hippocampal neurons (Benvegnù, Mateo, et al., 2017). As 
overall MGRN1 brain levels decrease with aging (Benvegnù, Mateo, 
et al., 2017), this phenomenon can in turn affect mitochondria ho‐
meostasis and consequently rise ROS production, and be one of the 
age‐related mechanisms responsible for increased oxidative stress 
that occurs during neuronal aging.
An additional challenging question is whether and how nucleo‐
cytoplasmic transport should be therapeutically targeted, given the 
high complexity of this process. Different strategies were shown to 
be beneficial to rescue neuronal death, nucleocytoplasmic transport 
defects, and nuclear morphology:
• Nuclear import:
Defects in nuclear import play a causative role in the pathogen‐
esis of ALS/FTD (Boeynaems, Bogaert, Van Damme, & Van Den 
Bosch, 2016; Kim and Taylor, 2017) and polyQ diseases similar 
to HD such as spinocerebellar ataxia type 3 (SCA3) (Sowa et al., 
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2018). While in some cases overexpression of importins was 
shown to be beneficial and neuroprotective (Guo et al., 2018; 
Jovičić	 et	 al.,	 2015),	 in	 other	 cases,	 depletion	of	 importins	 res‐
cued neurodegeneration (Sowa et al., 2018). The pathogenic 
mechanisms at the bases of the different diseases are still to be 
fully elucidated, and so the potential pharmacological interven‐
tion. Nevertheless, importins can become an important thera‐
peutic target not only for cancer therapy (Hill, Cautain, de Pedro, 
& Link, 2013), but also for neurodegenerative disorders.
• Nuclear export:
Partial inhibition of the exportin CRM1 was found beneficial in fly and 
neuronal models of C9orf72 (Zhang et al., 2015), in TDP‐43‐linked 
FTD (Chou et al., 2018), and in Huntington’s disease (Grima et al., 2017) 
by rescuing nuclear morphology defects and neuronal death (as previ‐
ously discussed in the text). The inhibition of nuclear export activity 
can confer neuroprotection by compensating the defects in nuclear 
import under different pathological conditions.
F I G U R E  1   Alteration of nucleocytoplasmic transport in brain aging and disease. In young neurons (left panel), oxidative stress and 
protein aggregates are minimal. The nucleocytoplasmic transport is therefore unaffected and properly functioning. This allows the 
physiological compartmentalization of both proteins and mRNAs. In aged neurons (central panel), the increase in reactive oxygen and 
nitrogen species (RONS) induces oxidative damage directly to the NPC. Additionally, the age‐dependent perturbation of proteostasis, 
together with the increase in oxidative stress, can favor the insurgence of both disease‐related and non‐disease‐related protein aggregates. 
These aggregates in turn affect the functionality of NPC, altering the proper nucleocytoplasmic compartmentalization. Neurons undergo 
a transcriptional response to age‐related stress (such as proteotoxic and oxidative stress), to counteract neuronal dysfunction and 
maintain homeostasis. However, a prolonged exposure to additional adding‐up stress can overwhelm the cellular capacity to elicit a proper 
transcriptional response—leading eventually to cellular damage and neurodegeneration. Indeed, in neurodegenerative brains (right panel), 
the presence of protein aggregates sequesters and alters the localization of importins and exportins, as well as of other nuclear transport 
factors and of transcription factors. Additionally, the protein aggregates can directly interact with the NPC, leading eventually to the 
disruption of the NPC functions and to the final imbalance of nucleocytoplasmic transport of both mRNAs and proteins. The aberrant 
nucleocytoplasmic compartmentalization and sequestration in protein aggregates of transcription factors and regulatory proteins affect 
nuclear transcriptional response, leading in turn to the suppression of neuroprotective transcription and, eventually, to loss of homeostasis 
and cell death
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• O‐GlcNAc transferase inhibition:
Huntington’s disease‐mediated neuronal death, Ran localization, and 
nucleocytoplasmic transport defects were also rescued with an inhib‐
itor of O‐GlcNAc transferase (O‐GlcNAcase, OGA). O‐GlcNAcylation 
is a posttranslational modification in which β‐N‐acetylglucosamine 
(GlcNAc) is added to intracellular proteins (Zachara and Hart, 2006), 
and it is essential for NPC integrity and function as well as for the 
maintenance of the pore selectivity filter (Zhu et al., 2016). Moreover, 
O‐GlcNAc is significantly decreased in mHTT‐expressing cortical cells, 
indicating that nucleoporins mislocalization could be due to decreased 
levels and/or misregulation of O‐GlcNAc. Inhibition of OGA resulted 
in elevated levels of O‐GlcNAc with consequent reduction of neuronal 
death and rescue of Ran localization and nucleocytoplasmic transport 
in mHTT neurons.
• Microtubule stability intervention:
Nuclear shape and nucleocytoplasmic transport were rescued by in‐
tervention on microtubule dynamics, with nocodazole in Tau‐linked 
FTD (Paonessa et al., 2019) and with a small NAT10 inhibitor molecule 
in HGPS (Larrieu, Britton, Demir, Rodriguez, & Jackson, 2014, Larrieu 
et al., 2018). The alteration in microtubule network and stability in 
the diseases deforms the nuclear membrane and the nuclear shape. 
The pharmacological intervention aimed at a microtubule reorganiza‐
tion is suggested to release mechanical forces acting on the nucleus, 
thereby contributing to a normalization of the nuclear shape and nu‐
clear functions.
Given these several options for intervention, it would be of 
extreme interest to understand the efficacy of the different treat‐
ments and interventions. For example, could these different phar‐
macological treatments be added up for an increased rescue activity 
in case of disease? How disease‐specific must be a multidrug ap‐
proach? Moreover, as these interventions have been made in dif‐
ferent laboratory species, cell lines and cultures, is there a limit for 
our intervention depending on the laboratory disease models used? 
Although there is still so much to be learned to answer these ques‐
tions, nevertheless this is a quickly moving field, and these issues will 
be surely addressed in the near future.
Additional questions remain. For example, the relative roles 
and interplays between the different neurotoxic aggregates and 
species causing damage to the nucleocytoplasmic transport are 
not yet resolved. Do their actions add up? Additionally, how the 
impaired nucleocytoplasmic transport affects other neuronal 
functions during aging is still unresolved. Why, in case of NPC 
dysfunction, are some proteins more affected in their subcellular 
compartmentalization, while other are more spared? Moreover, 
are all mislocalized proteins toxic to the neuron? Or, as the case of 
MGRN1, can the newly localized protein acquire or perform novel 
functions in a novel environment? If so, are these novel functions 
protective for the neurons? In addition, is there a potential ther‐
apeutic intervention on this system that can be undertaken to 
strengthen neuronal functionality during aging and, consequently, 
to potentially prevent neurodegenerative scenarios? The answers 
to these issues will shed additional light on mechanisms underlying 
all these processes and will indeed advance our understanding on 
different neurodegenerative disorders.
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